The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer.

[1]  P. V. van Diest,et al.  Micrometastases or isolated tumor cells and the outcome of breast cancer. , 2009, The New England journal of medicine.

[2]  P. V. van Diest,et al.  Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0[i+]) in the sentinel lymph node (SN): Results from the MIRROR study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Giuliano,et al.  Survey of ASCO Members on Management of Sentinel Node Micrometastases in Breast Cancer: Variation in Treatment Recommendations According to Specialty , 2009, Annals of Surgical Oncology.

[4]  L. Tafra,et al.  Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. , 2009, Journal of the American College of Surgeons.

[5]  P. V. van Diest,et al.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. , 2008, Journal of the National Cancer Institute.

[6]  S. Mclaughlin,et al.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Riedel,et al.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Ross,et al.  Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients , 2008, Annals of Surgical Oncology.

[9]  C. Hudis,et al.  Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Roland Holland,et al.  Image-detected breast cancer: state of the art diagnosis and treatment. , 2005, Journal of the American College of Surgeons.

[11]  A. Sapino,et al.  Meta‐analysis of non‐sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer , 2004, The British journal of surgery.

[12]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[13]  C. Cox,et al.  Significance of Sentinel Node Micrometastasis. , 1999, Cancer control : journal of the Moffitt Cancer Center.

[14]  B. Gusterson,et al.  Role of immunohistochemical detection of lymph-node metastases in management of breast cancer , 1999, The Lancet.

[15]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[16]  Donald L. Morton,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[17]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[18]  J. Russo,et al.  Predictors of recurrence and survival of patients with breast cancer. , 1987, American journal of clinical pathology.

[19]  R. Cabanas,et al.  An approach for the treatment of penile carcinoma , 1977, Cancer.

[20]  M. Mazumdar,et al.  Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures , 2001, Annals of Surgical Oncology.